Illness perceptions and explanatory models of viral hepatitis B & C among immigrants and refugees: a narrative systematic review. by Owiti, JA et al.
Illness perceptions and explanatory models of viral hepatitis B & C among
immigrants and refugees: a narrative systematic review.
Owiti, JA; Greenhalgh, T; Sweeney, L; Foster, GR; Bhui, KS
 
 
 
 
 
 
 
For additional information about this publication click this link.
http://qmro.qmul.ac.uk/jspui/handle/123456789/7599
 
 
 
Information about this research object was correct at the time of download; we occasionally
make corrections to records, please therefore check the published record when citing. For
more information contact scholarlycommunications@qmul.ac.uk
RESEARCH ARTICLE Open Access
Illness perceptions and explanatory models of
viral hepatitis B & C among immigrants and
refugees: a narrative systematic review
John A Owiti1*, Trisha Greenhalgh2, Lorna Sweeney2, Graham R Foster3 and Kamaldeep S Bhui1
Abstract
Background: Hepatitis B and C (HBV, HCV) infections are associated with high morbidity and mortality. Many
countries with traditionally low prevalence (such as UK) are now planning interventions (screening, vaccination, and
treatment) of high-risk immigrants from countries with high prevalence. This review aimed to synthesise the
evidence on immigrants’ knowledge of HBV and HCV that might influence the uptake of clinical interventions. The
review was also used to inform the design and successful delivery of a randomised controlled trial of targeted
screening and treatment.
Methods: Five databases (PubMed, CINHAL, SOCIOFILE, PsycINFO & Web of Science) were systematically searched,
supplemented by reference tracking, searches of selected journals, and of relevant websites. We aimed to identify
qualitative and quantitative studies that investigated knowledge of HBV and HCV among immigrants from high
endemic areas to low endemic areas. Evidence, extracted according to a conceptual framework of Kleinman’s
explanatory model, was subjected to narrative synthesis. We adapted the PEN-3 model to categorise and analyse
themes, and recommend strategies for interventions to influence help-seeking behaviour.
Results: We identified 51 publications including quantitative (n = 39), qualitative (n = 11), and mixed methods
(n = 1) designs. Most of the quantitative studies included small samples and had heterogeneous methods and
outcomes. The studies mainly concentrated on hepatitis B and ethnic groups of South East Asian immigrants
residing in USA, Canada, and Australia. Many immigrants lacked adequate knowledge of aetiology, symptoms,
transmission risk factors, prevention strategies, and treatment, of hepatitis HBV and HCV. Ethnicity, gender, better
education, higher income, and English proficiency influenced variations in levels and forms of knowledge.
Conclusion: Immigrants are vulnerable to HBV and HCV, and risk life-threatening complications from these infections
because of poor knowledge and help-seeking behaviour. Primary studies in this area are extremely diverse and of
variable quality precluding meta-analysis. Further research is needed outside North America and Australia.
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Background
Hepatitis B (HBV) and C (HCV) virus infections are
major threats to global public health currently associated
with increasing chronic morbidity and mortality rates
worldwide [1-3]. Chronic HBV and HCV infections are
responsible for nearly 57% of liver cirrhosis cases (HBV
30%, HCV 27%) and 78% of hepatocellular carcinomas
(HBV 53%, HCV 25%), the third commonest cause of
cancer deaths worldwide [4,5].
HBV is highly endemic in developing regions such as
South East Asia, China, Africa, the Middle East and the
Amazon Basin, where at least 8% of the population are
HBV chronic carriers [3] (Table 1). HBV is moderately
endemic in parts of Eastern and Southern Europe, the
Middle East, central Asia, South Asia, and parts of South
America [3]. The endemicity of HBV is low in most de-
veloped areas, such as North America, Northern and
Western Europe and Australia [3].
* Correspondence: j.a.owiti@qmul.ac.uk
1Wolfson Institute of Preventive Medicine, Barts and The London School of
Medicine and Dentistry, Charterhouse Square, Queen Mary University of
London, Centre for Psychiatry, EC1M 6BQ London, UK
Full list of author information is available at the end of the article
© 2015 Owiti et al.; licensee BioMed Central. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Owiti et al. BMC Public Health  (2015) 15:151 
DOI 10.1186/s12889-015-1476-0
In developing countries, HBV is often transmitted verti-
cally from infected mothers to their offspring, horizontally
in early childhood through exposure to infected children,
donor blood transmission, unsafe therapeutic injection
practices (and other healthcare-related procedures), or
through sex [7-9]. The main routes for transmission of
HCV are not clear but unsafe therapeutic injection and
medical practices and donor blood are mentioned [9,10].
The emergence of injecting drug users in settings where
the prevalence of HCV is high (Africa, the Middle East
and South East Asia) presents an additional threat [9].
The unprecedented rate of migration from high to low
prevalence countries may explain the increasing incidence
of chronic HBV and HCV infections and mortality rates
from hepatocellular carcinoma in North America and
Western European countries [11-16]. The proportion of
all immigrants chronically infected with HBV range from
3.7% to 9.7% in the different migrant-receiving countries
[17]. Compared with indigenous populations, higher rates
of chronic viral hepatitis infections, mortality, and morbid-
ity from hepatocellular carcinoma have been found among
ethnic immigrants in the Netherlands [18] UK [10,19,20],
Australia [21], USA [22], Canada [14], and France [23].
In the UK, over 95% of new chronic HBV infections
occur in immigrant populations [24]. Higher rates of
chronic HBV infections were found in immigrant women
attending antenatal screening in England [25,26]. In an-
other study of 15 specialist hepatic medicine centres in
the UK, 81% of the 1,147 patients with chronic HBV regis-
tered [27]. The UK’s Chief Medical Officer’s annual report
[28] highlighted undiagnosed viral hepatitis infection, pre-
dominantly in immigrants, as one of the three major
causes of liver disease, contributing to the dramatic rise in
liver cancer deaths in people under the age of 65 years.
However, immigrants and refugees from intermediate
and high prevalence countries are not routinely screened
for HBV and HCV infections, nor is hepatitis B vaccination
routinely given in most migrant-receiving countries [29].
Recent guidelines from the United States, Canada, the
European Union, and Australia identify immigrants origin-
ating from areas of intermediate and high endemicity as an
at risk group for HBV who should be screened routinely
and vaccinated for HBV [24,29-33]. The World Health Or-
ganisation’s ‘call to action’ demands an immediate increase
in prevention, screening, and treatment of HBV and HCV
infections [34]. In contrast, there is little public or policy
awareness of the health implications of chronic HBV and
HCV infections across the European Union [35] and immi-
grants are neither routinely screened nor vaccinated. In the
UK, though a national screening programme for HBV and
HCV does not exist [36], even though the National Insti-
tute of Health and Clinical Excellence has issued guidance
for systematic screening in first and second-generation im-
migrants from known countries of high prevalence [24].
In response to this, a cross-sectional cluster randomised
controlled clinical trial of targeted screening and treatment
through primary care (GP practices) in England (London,
Bradford, and Oxford) called the HepFree Trial (UKCRN
ID No. 14034) is currently examining the effectiveness and
cost-effectiveness among high-risk immigrants.
This narrative systematic review aimed to synthesise
evidence on knowledge (illness perceptions or explana-
tory models) of HBV and HCV infections among first
and second-generation migrants from high or inter-
mediate prevalence countries to traditionally low preva-
lence countries.
Methods
Inclusion criteria
Studies were included if they:
(i) used qualitative, quantitative or mixed methods to
examine knowledge of, and beliefs about, HBV
and/or HCV infections;
Table 1 Regional prevalence of viral hepatitis B and C
Prevalence of chronic HBV across the world Prevalence of chronic HCV across the world
Prevalence Areas of the world Prevalence Areas of the world
High prevalence >8% All of Africa; South East Asia (China, Korea,
Indonesia & the Philippines); The Middle East,
except Israel; South and Western Pacific Islands;
The interior Amazon basin; and certain parts of
the Caribbean (Haiti and Dominican Republic)
High prevalence >10% Egypt
Intermediate prevalence 2% - 7% South Central and Southwest ;Israel; Japan;
Eastern and Southern Europe; Russia;
Most areas surrounding the Amazon basin;
Honduras; and Guatemala
Intermediate prevalence >2% Countries in Latin America,
Eastern Europe, and many
countries in Africa, the Middle East,
and South Asia
Low prevalence <2% Northern and Western Europe; North America;
Australia; New Zealand ; Mexico;
Southern South America
Low prevalence <2% Northern and Western Europe;
North America Australia;
New Zealand
Adapted from: Centers for Disease Control and Prevention, 2014 [6].
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(ii)were carried out among first (foreign-born) and
second generation (descendants of at least one
foreign born) immigrant groups from countries of
high prevalence (Sub-Saharan Africa, North Africa,
Middle East, Asia, Latin America) or intermediate
(Southern and Eastern Europe) prevalence of HBV
and/or HCV infections who migrated to traditionally
low prevalence countries (North America, Western
Europe, Australia, and New Zealand);
(iii)were published in English in peer reviewed journals;
(iv) examined the participants’ experiences with HBV
and/or HCV infections and/or with screening,
vaccination and treatment; and
(v)were studies of mixed ‘low’, ‘intermediate’ and ‘high’
risk populations, and it was possible to attribute the
findings to specific immigrant population of interest
as defined above.
Studies that focussed on injecting drug users were only
included if the participants were first- and second-
generation migrants and refugees, and if they assessed
knowledge and attitudes of participants. Intervention
studies on HBV and/or HCV infections and associated
liver cancer, were included if they assessed people’s
knowledge, attitudes, or behaviour both before and after
the intervention.
Exclusion criteria
Studies were excluded if they focussed on:
(i) the general (non-immigrant) population groups;
(ii) groups at low risk of HBV and HCV infections; and
(iii)other populations at high risk such as injecting drug
users, prisoners, and men who have sex with men.
Search and selection
Search strategy
We developed an inclusive search strategy incorporat-
ing qualitative and quantitative studies. Seven electronic
databases (PubMed, CINHAL, SOCIOFILE, PsycINFO,
Web of Science databases (Science Citation Index Ex-
panded (1970-present) Social Sciences Citation Index
(1970-present), Arts & Humanities Citation Index (1975-
present), Conference Proceedings Citation Index- Science
(1990-present), Conference Proceedings Citation Index-
Social Science & Humanities (1990-present)), were inde-
pendently searched by two people in January 2013, and
updated in February 2014. The initial search used the
terms: ‘belief ’ OR ‘perception’ OR ‘culture’ OR ‘Know-
ledge’ OR ‘practices’ OR ‘narrative’ OR ‘explanatory model’
OR ‘awareness’ OR ‘views’ OR ‘reasons’ OR ‘perspective*’
OR ‘attitude*’ OR ‘motiv*’ AND ‘viral hepatitis’ OR ‘hepa-
titis B’ OR ‘hepatitis C’ OR ‘HBV’ OR ‘HCV’ OR ‘blood
borne virus’ OR ‘liver infection’ OR ‘liver disease’ OR
‘hepatocellular carcinoma’ OR’ liver cancer’ OR ‘jaundice’.
The search was then limited by restricting it to those refer-
ences containing ‘refugee* OR ‘marginal group’ OR ‘min-
orit*’ OR ‘disadvantaged group’ OR ‘asylum seeker’ OR
‘migrant’ OR ‘immigrant*’.
We also searched web-based sources (e.g. Google
scholar, NHS Evidence collection on ethnicity and health,
Allied and Complementary Medicine Database (AMED),
Health Management Information Consortium (HMIC)
and Project MUSE). The following journals were hand
searched: Journal of Immigrant and Minority Health,
Journal of Community Health, Australian Health
Review, Gastroenterology Nursing, International Journal
of Drug Policy, Journal of Health Care for the Poor and
the Underserved, and Journal of Viral Hepatitis. All
sources were subjected to forward and backward citation
tracking. Review articles were searched through the JBI
register and Cochrane Database for Systematic Reviews.
Selection
All hits were initially considered for relevance on the
basis of the title and abstract. Irrelevant studies were
systematically excluded (based on exclusion and inclu-
sion criteria) as detailed in the PRISMA search strategy
flow chart (Figure 1). Full text articles were obtained for
all those that seemed to meet inclusion criteria, and
where it was not possible to make a confident judgement
on the basis of the title and abstract. Full articles were
further assessed for eligibility following the inclusions
and exclusion criteria.
Data analysis
Appraisal of the studies
We used Mixed Methods Appraisal Tool (MMAT) -
Version 2011, a scoring system for appraising the meth-
odological quality of qualitative, quantitative, and mixed
methods studies [37,38]. Two people (JAO and KSB)
appraised the articles independently and compared the
outcomes. Any disagreement was resolved through dis-
cussion and consensus. We did not exclude any study
published in a peer-reviewed journal on the basis of ap-
praisal as some studies that were classed as low meth-
odological quality (for example on the basis of small
sample size) contributed to the overall findings and to
the overall aim of identifying varied forms of know-
ledge. We did, however, use consensus when deciding
whether a finding reported in a study was valid. Hetero-
geneity of study design, populations and instruments
precluded formal meta-analysis of quantitative data.
Data extraction
Two people independently extracted data from the arti-
cles. Study details including location, aims, demographic
data, study design, sample, and data on knowledge of
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HBV and HCV infections were tabulated. The latter
findings were extracted, by interrogating each study
using the conceptual framework of explanatory model
[39] as presented by the theoretical framework used.
Theoretical framework
We used Kleinman’s explanatory model as our theoretical
framework [39]. The explanatory model of an illness or in-
fection offers conceptual and culturally-specific frame-
works for understanding how different cultural and social
contexts affect the ways that people understand, and nego-
tiate their experiences with illness or infections. The fol-
lowing are the main elements of an explanatory model of
illness: aetiology, symptoms, pathophysiology, history and
severity (course), and treatment [39,40]. We modified the
explanatory model framework to accommodate forms of
knowledge applicable to communicable infections such as
transmission factors and preventive methods. We were
also interested in people’s experiences with these infec-
tions, including screening, vaccination, and treatment. We
extracted data on the knowledge of HBC and HCV
infections and organised them around the following
themes: concepts (identity) of HBV and HCV; signs and
symptoms; causes; transmission; prevention; conse-
quences; and treatment.
Synthesis
We synthesised outcomes from relevant articles using
the process and techniques of narrative synthesis ap-
proach to develop a robust understanding of knowledge
of HBV and HCV infections. Narrative synthesis is use-
ful in synthesising heterogeneous evidence of different
types (qualitative and quantitative) [41,42]. Data were
initially extracted and grouped into tables according to
methods, theoretical frameworks, and focus of studies.
All data (from quantitative and qualitative sources) were
integrated for complementarity [43,44] and to improve
on depth of understanding of the level, and type, of
knowledge of HBV and HCV infections. In fact, a
mixed-methods systematic narrative review has parallels
to the process of triangulation or cross-validation in data
synthesis [45]. Survey studies provided quantified levels
Figure 1 PRISMA Flowchart of search and studies selection.
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of knowledge of HBV and HCV in scores (as a % of the
correct answer), and these have been pooled together
(with low scores indicating a knowledge deficit), but
could not be statistically combined. All data were inter-
rogated, interpreted, and organised into a priori thematic
categories or elements of the explanatory model, as out-
lined in the theoretical framework.
We have also adapted the PEN-3 model to further cat-
egorise and analyse themes, and to demonstrate specific
strategies and approaches for specific areas of interven-
tions to influence health-seeking behaviour. PEN-3
model was originally developed to situate culture at the
centre of health-seeking behaviour in health promotion
and disease prevention [46-48], and emphasises the
meeting and working with beliefs of participants rather
than only aiming to change them.
Results
Two hundred and sixty one studies were screened as po-
tentially relevant out of which 80 full text articles were
fully assessed for eligibility according to inclusion and ex-
clusion criteria (Figure 1). We identified 51 relevant peer-
reviewed journal articles, published in English [49-99]
(Additional file 1: Table S1). In our appraisal of methodo-
logical quality, most surveys (n = 20) and qualitative stud-
ies (n = 9) had 2 and 3 star ratings (out of a maximum of 4
stars) respectively (Table 2). Salient issues that affected the
quality of the studies included inadequate reporting of re-
search methods, sampling methods, unclear research con-
text, lack of reporting of response rate, and low response
rates (<60%). Only 19 survey studies reported response
rates of more than 60%.
Most studies (64%) had been conducted in the USA
(Table 3). Most were cross-sectional surveys that fo-
cussed on HBV infection (84%) (Table 4), and drew their
samples from the general immigrant populations in the
community (n = 37, 72.5%) (Table 5). One online survey
included some open-ended questions [53]. One mixed
methods study had community-based participants, and
identified those with chronic HBV infection for in-depth
interviews [69]. Three studies were carried out with par-
ticipants with chronic HBV infection, and one was con-
ducted among injecting drug users with HCV infection.
Most studies examined the views and experiences of
South East Asian immigrants from China, Korea,
Cambodia, and Vietnam in USA, Canada, or Australia; with
only two focussing on other non-Asian ethnic groups-
Turkish and Egyptian immigrants (see Table 6). The cross-
sectional survey studies (Additional file 1: Table S2) used a
variety of survey questionnaires derived from diverse theor-
etical models: seven were based on the constructs of Health
Behaviour Framework [49,59,74-76,81,87]; one study [86]
used Predisposing, Reinforcing and Enabling Constructs in
Educational Diagnosis and Evaluation (PRECEDE) frame-
work [100]; and six surveys used adapted questionnaires
from published studies that used the Health Belief Model
[52,53,60,67,69,94]. Other surveys (Additional file 1: Table
S3) did not clearly indicate the theoretical frameworks that
influenced their choice of survey questions and used differ-
ent methodologies, and focussed only on HCV, or HBV
and HCV together, with none focussing only on HBV
[54,57,62,63,66,71-73,77,80,82,84,85,88-90,93,97-99].
Qualitative studies (Additional file 1: Table S4) used
various methods: combination of open-ended interviews
and focus groups [51,58,95]; focus group [50,55,68,78,91];
semi-structured and in-depth interviews [56]; observa-
tional and in-depth interviews [65]; and ethnography [61].
A mixed methods study used both survey questionnaires
based on Health Behaviour Framework and in-depth-
interviews [69] (Additional file 1: Table S5).
Most of the surveys used a convenience sample (e.g.
attendees of health clinics or community events). Even
though, surveys were administered in the language of
the participants, and many had good response rates,
many relied on telephone surveys, which may have ex-
cluded participants who did not have telephones or take
phone calls; and the reliance on self-reported data may
have skewed some of the results. In addition, because of
the diverse data collection methods in surveys, compar-
ing data across studies as well as ethnic groups was only
possible to a very limited extent.
The findings derived from the data were synthesised
according to the explanatory model framework and pre-
sented in specific categories of: concepts of HBV and
HCV; symptoms; causes; transmission; prevention; con-
sequences; and treatment of HBV and HCV infections.
Table 2 Quality ratings for studies
1 star
(25%)*
2 stars
(50%)
3 stars
(75%)
4 stars
(100%)
Survey studies (n=) 2 20 14 2
Qualitative studies (n=) 2 9
Mixed methods (n=) 1
*Key - scores: 1 star (25%) one criterion met; 2 stars (50%) 2 criteria met; 3 stars
(75%) 3 criteria met; and 4 stars (100%) met all 4 criteria.
Table 3 Location of studies by country
Countries Number
of studies
Sources
USA 32 [48-52,54,57-59,66,67,69,71-75,77-88,95,96,98]
Australia 8 [53,60,61,64,65,76,93,94]
Canada 5 [56,63,70,89,97]
Netherlands 3 [90-92]
Canada and USA 1 [55]
Mexico and USA 1 [62]
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The concepts of hepatitis B and C infections
In their descriptions of HBV infection, South East Asian
participants (Vietnamese, Cambodians, Chinese and
Koreans) appropriated biomedical information and used
terms such as ‘liver sickness’, ‘liver disease’, and ‘liver can-
cer’ [50,51,56,58,78,95]. Cambodians referred to HBV in-
fection as ‘blood disease’, ‘bad blood’, ‘contaminated blood’,
‘unclean blood’ and ‘yellow skin’ [50]. Some Vietnamese
participants [84] used the term, benh viem gan B, which
translates to mean HBV. Participants from Hmong ethnic
group who had HBV referred to it as “mob ntshav daj”,
meaning “illness that makes your blood yellow” [69].
Two surveys [56,64] and three qualitative studies
[50,68,95], reported on participants’ confusion about
different types of viral hepatitis. For instance, a study in
Australia found that some South East Asians with chronic
HBV understood ‘viral hepatitis’ as existing at three levels
- A, B, and C, with C being the worst. Some participants
perceived linear and progressive stages of the same illness
evolving from hepatitis A, to hepatitis B, and then to hepa-
titis C [50,95]; and some considered that this might pro-
gress further to immunodeficiency virus (HIV) [95]. In
another study, however, respondents perceived hepatitis A
as deadly, B as not very good, and C as okay; with some
offering explanations using different anatomical locations
of the infections: hepatitis A is on the skin only, while B
reaches the liver [50].
The symptoms of hepatitis B and C infections
Some of the Chinese, Vietnamese, and Korean participants
associated HBV infection with symptoms such as ‘yellow
skin’, ‘yellow eyes’, ‘yellow blood’ and ‘fatigue’ (‘looking
tired’) [50,56,58,95]. In addition, Cambodians associated
HBV infection with ‘tough liver’, ‘swollen belly’, and ‘dys-
functional liver’ [50]. Between 23% to 83% of participants
knew of transmission risk by healthy looking subjects
[49,53,59,60,64,67,69,76,81-83,85-99], and recognised that
HBV infection can be asymptomatic.
Though inter-ethnic differences were found, whereby
Cambodian participants in two studies had the least
level of knowledge (23% and 43%) compared to other
South East Asian groups, there are also intra-ethnic dif-
ferences as evidenced in the way that different studies
found both high and low levels of knowledge in Chinese
participants.
The causes of hepatitis B and C infections
The causes of HBV and HCV were attributed to many fac-
tors in various studies (Table 7 provides a detailed synthe-
sis). Vietnamese, Chinese and Korean participants in some
studies believed that a ‘weak liver’ causes HBV rather than
vice versa. Various factors such as harmful foods [51,56],
stressful lifestyle [78], hormones [51], poor nutrition [68],
environmental pollutants [51], smoking [56], and alcohol
[56] were perceived as causing weak liver, which in turn
Table 4 Methods used in studies
Methods of studies Focus Number of studies Sources
Cross-sectional surveys HBV 34 [48,51,55,56,58,59,63,66,68-75,78-89,92,93,95,97,98]
HCV 2 [61,65]
HBV & HCV 3 [53,62,76]
HBV & Liver cancer 2 [57,96]
Qualitative studies HBV 5 [50,54,67,90,94]
HCV 1 [60]
HBV and HCV 1 [64]
HBV & liver cancer 2 [49,77]
Mixed methods HBV 1 [52]
Table 5 Participants in, and focus of, studies
Type of participants Number of studies Focus Source
General populations 46 HBV [48-51,55,56,58,59,63,66,67,69-75,78-84,86-93,95,97,98]
HCV [61,65]
HBV & HCV [53,62,76]
HBV & liver cancer [54,57,77,96]
Blood-borne viral infections [64]
People with chronic HBV 2 HBV [94,97]
Injecting drug users with HCV 1 HCV [59]
General population and people with HBV 1 HBV [52]
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was seen to cause HBV. In one study, Vietnamese partici-
pants attributed the causes of weak liver to hard labour,
starvation, political persecution, and physical deprivations
that the Cambodians and Vietnamese experienced in
prisons and camps during war [51].
Lay explanations of cause(s) of HBV in different stud-
ies among South East Asians included poor sanitation
and hygiene [50,95] and biological factors such as genes
and hormones [50,70,78,80]. The cause of HBV was
popularly attributed to stress and negative emotions
[51,70,78,80], karma or fate [49-51,78,87], ‘imbalance’ in
the body [50,51,56,78], and lifestyles factors such as fa-
tigue [56,67,68]. Only Cambodian participants mostly at-
tributed the cause of HBV to food [50], while Chinese,
Vietnamese and Korean participants also mentioned al-
cohol [68,78]. The attribution of cause of HBV to smok-
ing and bacteria were only made by the Vietnamese [76]
and Cambodians [50] respectively.
Transmission of viral hepatitis B and C infections
Immigrants attributed the transmission of HBV and HCV
to many factors (Table 7). Korean, Chinese, and Vietnamese
participants perceived HBV infection as contagious
[55,56,58,78], and easily transmissible through multiple
routes that are related to daily activities such as food or
physical contact with infected people or objects [56,78,95].
The various surveys showed that 19% to 80% of South
East Asian participants knew that HBV could be sexually
transmitted [49,52,53,59,60,64,67,69-73,76,77,80-99]. There
were both inter- and intra-ethnic as well as regional varia-
tions in the level of this knowledge. For instance, only 1 in
5 (19%) participants among Koreans correctly identified
sexual behaviour as a risk factor [67], which is at the lower
range of estimates reported by similar studies of Chinese
and Vietnamese immigrant populations in the United
States and Canada [64,73,85,88]. In terms of intra-ethnic
and regional differences, awareness of sexual transmission
risk was found to be as low as 23% in Philadelphia, to as
high as 71% in Seattle, among Vietnamese immigrants
[67,72,82,87,88,94], compared to a range of 40% to 80%
among Chinese in the Netherlands, USA, and Canada
[59,60,64,71,72,85,93,94,97,98].
Factors perceived to increase the risk of horizontal
transmission in surveys were: contact with contami-
nated blood or other body fluids from infected person (re-
ported by 61% to 90% of participants) [53,60,67,80,97];
premasticated food (reported by 63% to 82% of partici-
pants) [53,69,81,82,88-90]; contaminated drug injecting
needles and syringes (reported by 59% to 86% of partici-
pants ) [53,67,69,82,97]; sharing of toothbrush (reported
by 33% to 86% of participants) [49,52,53,67,69,72,73,76,
81-84,87-90,94,97]; and sharing of razors (reported by 55%
to 80% of participants) [53,64,69,82,84,85,88,97]. The level
of knowledge of transmission through sharing of tooth-
brush was lowest among the Samoa and Chamorro [80]
and Hmong [52], with evidence of intra-ethnic variation
among the Vietnamese ranging from 42% to 77%
[67,72,76], probably due to different sample sizes.
South East Asians commonly attributed transmission
of HBV infection to factors such as contaminated and
uncooked or poorly cooked food [53,58,60,67,69,80,97] and
communal sharing of food and drinks [50,51,56,58,78,95].
Surveys showed that between 21% and 71% of participants
believed that HBV infection could be transmitted
through eating of food prepared by an infected person
[53,64,69,72,73,81-85,88-90], and between 26% to 48%
of the Chinese participants [71,80,98] knew that HBV
infection could be transmitted through sharing of food
and drinks. Between 15% to 89% of participants knew
that HBV infection could be spread through sharing
utensils [49,60,64,69,70,72,76,80,84,85]. The attribution
of transmission of HBV through food and sharing of
utensils is particularly influenced by the cultural prac-
tices around food preparation, and eating and drinking
habits among the South East Asians [51,58,68,95]. In a
number of studies, 58% to 76% of participants also be-
lieved that HBV infection could be transmitted through
holding hands [69,81,82,84,88-90].
Between 34% and 91% of participants in surveys knew of
the vertical transmission of HBV infection through child
birth [49,52,59,60,64,67,69-71,74-76,80,83-88,92-94,97,98].
This knowledge was low in some studies with Korean par-
ticipants (34%) [70] and Samoa and Chamorro participants
(38%) [80], but tended to be high among Chinese partici-
pants (range 76% to 91%) [59,60,71,85,94]. Nonetheless, the
results from different studies indicate intra-ethnic varia-
tions, as the level of knowledge of this risk factor is low
among Koreans in Rocky Mountain [70], but high among
Koreans in Los Angeles [49], Vietnamese Americans (59-
Table 6 Populations of focus
Populations Number
of studies
Sources
Chinese 16 [53,55,56,58,59,63,70,72,73,84,88,89,92,93,96,97]
Vietnamese 13 [50,64,66,71,74-76,81,85-87,93,95]
Cambodian 6 [49,53,74,80,82,83]
Korean 4 [48,57,69,74]
Mixed
Asians
7 [52,60,61,67,77-79,94]
Laotians 2 [53,98]
Hmong 4 [51,52,68,74]
Turkish 2 [90,91]
Egyptians 1 [65]
Mexican
Americans
1 [62]
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Table 7 Categorisation of the outcome data according to the explanatory model framework
Theme Category Subcategory
The causes of
HBV and HCV
Damaged liver/weak liver [50,55,67,77]
Genes and hormones [50,65,77,79]
Stress and negative emotions [50,51,55,67,77]
Supernatural beliefs & kama/fate [48-50,77,86]
Poor sanitation and hygiene [49,94]
Alcohol [61,67,77]
Smoking cigarettes [75]
Food/diet [49,66]
Physical exhaustion and fatigue [55,67]
Internal and external imbalance [49,50,68,77,79]
Fatigue [66]
Bacteria [49]
HBV and HCV
transmission factors
Sexual transmission
[48-52,58,59,61-63,66,68-72,75,76,79-93,96-98]
Intravenous needles for drugs [52,60,61,64,66,68,76,81,96]
and other drug injecting paraphernalia - spoons, swabs,
water, tourniquets, and filters [60,61,64,76]
Through child birth or pregnancy
[48,50-52,58,59,61,63,65,66,68-71,74-76,79,82-87,91-93,96,97]
Mosquito bites [61,64,65]
Poor hygiene/sanitation [49,77,79]
Contact with contaminated objects/materials [55,57,77,79]
Tattoos and body piercing [60,61,65,76]
Environment Remoteness of a place [49]
Poor conditions of living [49]
Farming (livestock and poultry) [49]
Contact with blood and other body fluids Blood [52,57,59,66,79,96]
Saliva [64]
Cough and nasal discharge [49,69,74,75,80-83,87-89,98]
Breast milk (breast feeding) [61]
Premasticated food [80,81,87-89]
Eating and drinking practices Eating food prepared by an infected
person [63,68,71,72,80-84,87-89]
Sharing food & drinks with an infected person [67,70,79,97]
Sharing eating utensils [48,59,61,63,65,67-69,71,75,79,83,84]
Consumption of contaminated food [57,61,66,79,96]
Consumption of raw food [59,79]
Drinking contaminated water [61,67]
Intact person-to-person contact Hugging [55,61,65,71,92]
Shaking hands [55,61,65,71,92]
Holding hands [55,80,81,83,87,89]
Kissing [77,79]
Non-intact person-to-person contact Bites or wounds [64]
Open mouth ulcer [64]
Sharing personal items Sharing toothbrush [52,61,65,68,69,71,72,75,80-83,86-89,93,96]
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Table 7 Categorisation of the outcome data according to the explanatory model framework (Continued)
Sharing razors, blades and scalpels
[52,57,60,61,63,65,68,81,83,84,87,96]
Sharing earrings [50,79,81]
Iatrogenic transmission Sharing needles for injections [66,71,72,75,79,83,98]
Medical equipment [93]
Traditional healing practices – coin rubbing,
cupping & moxibustion [61], acupuncture
[61,87] and lancet therapy [87]
Blood transfusion [50,52,57,61,62,65,77]
Heredity Genes [69,79]
Prevention of
HBV and HCV
Vaccinations
[51,52,54-57,59,62,65-67,70-72,77,78,84,90,91,94,96,98]
Screening [54,59,62,71,72,74,78,86,90]
Good hygiene practices [55,57,59,67,72,78,90]
Avoid contact with blood and other body fluids [61,78]
Avoid sharing drug injecting needles/paraphernalia [61]
Condoms [65]
Not taking illicit drugs [78]
Traditional medicines [49,55,58,67]
Regular hospital check-up [78]
Consumption of clean and properly
cooked food [76,78,81,82,84,87,88,96]
Avoid infected needles [52]
Clean water [52,66,72,78,81,82,84,85,88,96]
Altering eating and drinking practices Not sharing utensils and food
[55,57,61,67,72,78,81,82,84,87,88,96]
Not eating in restaurants [78]
Adopting healthy lifestyles and practices Good nutrition & balanced/healthy
diet/healthy living [55,67,71,78,85]
Regular exercise [55,67,77,78,87]
Enough rest [55,67,77,87]
Stress-free mind and positive attitude [55]
Abstain from smoking [55,78]
Abstain from drinking alcohol [55,78]
Avoid contact with infected individuals No kissing [55,67,78]
No touching [55,67,78]
No hugging [55,67,78]
No contact with infected individuals [55,67,78]
Avoid public spaces [78]
Avoid public bus [78]
Avoid sharing personal effects Not sharing razors & shaving blades [78]
Not sharing toothbrush [61,78]
Not sharing soap [61]
Consequences of HBV
and HCV infections
Chronic infection
[48,52,58,59,62,63,70,74-76,80-82,84,86,88,91-93,98]
Depletion of energy from the body [86]
Depression [68]
Death [48,52,68,75,80,81,85,86,88,89,91,92,94,96,98] Short life expectancy [52]
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85%) [67,72,75,86-88], and Vietnamese Australians (67%)
[94]. In contrast, a single study of Chinese and Vietnamese
Australians showed no significant ethnic differences in the
level of knowledge of this mode of transmission [94]..
There is evidence of knowledge of transmission of
HBV through contaminated (therapeutic) injection prac-
tices [51,58,63,67,72,73,76,78,80,84,88,94,99]. The pro-
portion of survey participants who knew of this risk
factor varied between studies from 18% to 92%
[67,72,73,76,80,84,99]. The level of knowledge of this
risk factor was low among the Laotians [99], but high
(92%) among the Cambodians [84]. There was evidence
of both intra- and inter-ethnic variations among the
Vietnamese ([67,72,76]; between 50% to 85%) and Chinese
([73,97]; between 52% to 85%).
Some immigrants knew that HCV infection could be
transmitted vertically through child birth and breast feed-
ing [62,66], or horizontally through sex [62,63], blood
transfusion [62,63,66], intact skin contact (such as hugging
and shaking hands [62,66]), non-intact skin contact (such
as bites or wounds [65] and open mouth ulcer [65]), tat-
tooing and body piercing [61,62,66,77], razors and shav-
ing blades [61,62,66], sharing of contaminated drug
injecting paraphernalia [61,62,65,77], sharing tooth-
brush [62,66], and traditional healing practices (such coin
rubbing, cupping, moxibustion, and acupuncture) [62].
Some immigrants also believed that HCV could be trans-
mitted through ingestion of contaminated food [62], water
[62,68], sharing of utensils [62,66] and saliva [65].
Some studies suggests that the framing of the trans-
mission of HBV infection within a broader issue of sexu-
ally transmitted disease [49,55,65,78,91,95], and injecting
drug use [61,65,95] contributed to its association with
shame and stigma.
Prevention of viral hepatitis
Immigrants explained the prevention of HBV and HCV
in various ways (Table 7). Survey studies showed that
between 54% and 96% of participants knew that HBV
could be prevented through vaccination [49,52,53,
Table 7 Categorisation of the outcome data according to the explanatory model framework (Continued)
Poor health [52] High blood pressure [81,89]
Stomach ulcer [81]
Discrimination and stigma Discrimination [52,64]
Stigma [48,52,54,59,60,64-66,70,74,77,90,93,97]
Avoidance [48,54,58,64,66,74,75,77,86]
Isolation [52,54,94]
Parental rejection [90]
Fear for the future [48]
Burdening the family [48,90]
Shame [48,52,60,90]
Loss of income Loss of employment [52]
Un-employability [48,52,90]
Loss of social status Not having children [52]
Spoilt identity [60]
Impediment to future marriage [90]
Liver disease Liver cancer [48,51,52,56,58,59,62,63,66,68-75,80,
81,83-86,88,89,91,92,96-98]
Liver cirrhosis [49,52,55-57,59,62,63,66,70,84,94,96,97]
Adversely affect liver [49,55,57,94]
Liver failure [52]
Treatments for HBV
and HCV infections
Hospital treatment/medicine [61,67]
Good nutrition [67]
Lifestyle changes Adequate rest and meditation [67]
Physical Exercise [67]
Avoid alcohol [67]
Indigenous medicines Acupuncture [49,50,61,67,71,73,78]
Herbal remedies [49,50,55,67,78]
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57-60,67,71,72,92,97-99], with no significant difference
among the ethnic groups, or wide intra-ethnic variation
between studies. However, despite the relatively high
level of awareness of vaccination for HBV, some of these
studies indicate that the levels of self-reported vaccin-
ation rates in the Asian-American populations were low
[56,58,72,81,85,87,88,90,97].
Studies that explored immigrants’ experiences with
vaccination have found mixed results among and be-
tween ethnic groups. While some Chinese [55,58,91],
Koreans [55,58,91], and Turkish-Dutch [55,58,91] partic-
ipants’ attitudes towards vaccination were generally posi-
tive and many were receptive to being vaccinated, others
(among South East Asian groups) were confused and
uncertain about the purpose of vaccination, its cost, effi-
cacy and benefits (including side-effects), and the num-
ber and frequency of shots needed [50,55,56,58,68,95].
The lack of provision of adequate information on HBV
vaccines and process of vaccination by healthcare pro-
fessionals appeared to add to the confusion among
Chinese participants [56]. As such awareness about the
knowledge of the existence of vaccines for HBV did not
translate into acceptance that vaccination should be used as
the primary means of preventing HBV infection among this
Chinese group [56]. However, some south East Asian par-
ticipants were found to perceive vaccination positively fol-
lowing active recommendations by doctors and healthcare
providers [59,61,64,71,72,76,87,90,97], family or friends or if
it was compulsory for employment or school admission
[58,67,90]. In addition, some participants from Chinese, Pa-
cific Islanders, and Vietnamese immigrants indicated that
targeting the whole family for intervention might positively
influence uptake of screening and vaccination [79,80,87].
In relation to attitudes to screening, surveys showed that
32% to 94% of South East Asian participants (Chinese,
Vietnamese, Hmong and Koreans) were aware of the avail-
ability of screening for hepatitis B infection [60,72,73,75].
There were high intra- and inter-ethnic and regional varia-
tions in levels of knowledge of screening as a means of
preventing hepatitis B infection. For instance, knowledge
of screening was low (32%) among the Vietnamese in USA
[72,75], but higher among Koreans (94%) in the USA
[60,72,75] and Chinese in Canada [71,73] . It is not clear
why the Vietnamese in Philadelphia and New Jersey had
poor knowledge of screening compared to other commu-
nities, though this is also reflected in low levels of rates of
screening among other Vietnamese immigrants (around
6% to 8%) [72,82,96], suggesting that better knowledge
might influence uptake of screening.
Though some immigrants expressed general motivation
to, or actively sought, screening [55,56,87,91,95,97,99] to
prevent liver disease [63,75,87], some with experience of
screening held mixed views. To some Cambodian, Chin-
ese, and Vietnamese participants, screening caused shock
and anxiety due to lack of provision of adequate informa-
tion at pre-screening and post-screening stages by health-
care professionals, and in some cases people were
routinely tested without explicit consent [95]. That created
considerable confusion and fear as people were not only
unaware of the likely impact of the infection on their
health. These experiences might also influence future
health-seeking behaviours of immigrants.
In addition, lack of provision of adequate health infor-
mation led to missed opportunities for provisions of
knowledge and information about viral infections which
could have provided avenues for health promotion and
behaviour change [95]. The evidence also suggests that
a better knowledge of screening process and procedures,
and comprehension of test results might positively influ-
ence engagement with screening and vaccination
[49,55,56,79,95].
Some evidence also suggests that compulsory screen-
ing [91], and the recommendation by healthcare profes-
sionals might be positively associated with uptake of
screening and vaccination [59,61,64,71,72,76,90,97]. The
perceived advantages of ‘targeting’ might partly be due
to its resonance with some of the migrants’ experiences
with active public health interventions, including com-
pulsory screening and vaccinations in their countries of
origin [58].
The consequences of hepatitis B & C infection
Participants in qualitative studies and surveys considered
that HBV and HCV infections led to both health-related
problems (liver cirrhosis, liver cancer, chronic infection
and death) and socio-economic ones (discrimination and
stigma, loss of income, and loss of social status) (Table 7).
The awareness of consequences of HBV infection in-
cluded liver cirrhosis (reported by 40% to 98% of
participants) [57,60,64,67,71,85,97,98]; liver cancer (re-
ported by 25% to 92% of survey participants)
[53,69,75,76,81-83,85-87,89,90,92-94,97-99]; chronic infec-
tion (reported by 24% to 75% of survey participants)
[49,53,59,60,64,69,71,75,76,81-83,85,87,89,90,92-94,99]; and
death (reported by 36% to 93% of survey participants)
[49,53,69,76,81,82,86,87,89,90,92,93,97,99]. Findings from
qualitative studies showed that some South East Asian par-
ticipants (Cambodian, Hmong, Korean, and Chinese) were
aware that HBV infection could cause liver cancer and/or
liver failure [50,53,56,58,63,69,95].
In relation to stigma and shame, between 36% to 70% of
South East Asian participants in surveys believed that
people with chronic HBV infection are sometimes avoided
by others [49,55,59,65,67,75,76,78,87]. This avoidance was
perceived to occur both at the family and community
levels [53,55,78,95,98]. Some Turkish-Dutch [91] partici-
pants perceived an infection with HBV as an impediment
to future marriage and employment. Some South East
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Asians also associated HBV infection with impediment to
getting employment [49,53,91]. Shame and stigma might
negatively influence uptake of screening; and those who
test positive might not disclose their test results [95,98],
and might continue to spread infections or develop
fatal sequelae.
Treatments for hepatitis B & C infections
In nine surveys, between 44% to 96% of the partici-
pants knew about treatments for HBV infection
[52,60,71,75,83,87,94,98,99]. One survey also reported
knowledge of lack of effective treatment for HCV
infection [66].
Some of the studies included in this review identified
varying levels of beliefs or perceptions (correct or other-
wise) of the nature and range of treatments for HBV and
HCV infections including internal and external restor-
ation of balance through lifestyle changes and good nu-
trition [68]; indigenous medicines [50,51,68,79]; and
hospital medicine [50,68] (Table 7). Evidence indicates
that South East Asian (Cambodian, Vietnamese, Chinese,
and Korean) immigrants residing in North America,
mainly base their treatments for HBV on lifestyle
changes, diet, and restoration of internal and external
balance in the body [50,51,68,79]. Even if people use
hospital (Western) medicine to treat symptoms of HBV
infection [50,68], they also use traditional medicine be-
cause of its affordability [68], or as a last resort when the
former fails to effectively cure HBV infection [50,51,68].
The only study that investigated Indo-Chinese
(Cambodian, Lao, and Vietnamese), immigrants’ expe-
riences with treatments identified key aspects of ser-
vice experience including long waiting lists, problems
with obtaining a doctor’s referral, and difficulties with
making and keeping appointments [61]. Even though
the study’s sample comprised only injecting drug users,
the findings could have implications for interventions
across immigrant groups.
The correlates of knowledge of HBV and HCV infections
Variation in the levels of various forms of knowledge of
HBV and HCV among and between ethnic groups is in-
fluenced by several factors. Some of the surveys exam-
ined some of these correlates of knowledge. Better level
of knowledge of HBV was related to socio-economic and
demographic factors such as higher levels of education
[56-58,70,75,84,87-90,93,97,98], income [57,75,88-90,98],
and English proficiency [56,58,67,70,75,77,81,84,90]. Even
though there is evidence from surveys [60,75,79,84,98]
and qualitative studies [50,78] that indicate a correlation
between younger age and better knowledge, this was not
significant in some surveys [82,83,97]. Similarly, inconclu-
sive evidence implies that better knowledge of HCV is cor-
related with higher levels of education [66], younger age
[66,69], house ownership [57,82,88-90], employment
[66,77], having had vaccination for HBV [77] or having
sought preventive care [69]. In addition, being aware of
HBV [57,88-90], and having received health education
through mass media [57,88-90] was correlated with better
knowledge.
Personal experiences with HBV infection [56,58,60,
91,95], having a family member with HBV or liver cancer
[50,60,67,81,97], screening [64,67,71,73,76,94,97], and vac-
cination [67,94] were associated with better knowledge;
though in one study, individuals who had a personal or
family history of HBV or liver cancer were more likely to
have been screened, but they did not have better knowledge
of HBV [97]. Evidence from one qualitative study among
those with chronic HBV, also suggests that people who had
access to specialist care [98] had better knowledge about
the infection.
In some studies, being born in a host country (USA)
[69,84] was correlated with better knowledge of HBV.
Even though younger age at immigration might be posi-
tively correlated with better knowledge of hepatitis B
[84], the longer immigrants stay in host country, the
more they associate HBV and HCV with stigma [95].
However, given the small number of studies in this area,
these conclusions are preliminary.
There was variation among ethnic groups (e.g.
Koreans, Cambodians, Vietnamese, and Chinese) on the
level, and type, of knowledge of HBV, including attitudes
towards, and understandings of, vaccination, screening,
treatment, reception of medical advice, and stigma
[57,68,75,78,82,85,94,97]. For instance, the Chinese and
Korean groups discussed vaccination as a preventive
measure more so than the Vietnamese groups [68]. Com-
pared to Chinese and Vietnamese groups, Koreans did not
understand the significance of screening prior to vaccin-
ation or taking up vaccination when one is healthy [68].
More often than other groups, Chinese participants men-
tioned poor hygiene, and Vietnamese groups mentioned
drinking alcohol as a cause of HBV infection [68]. There
were also differences in the perceptions of stigma by eth-
nic group: only 30% of Vietnamese respondents believed
that people with HBV infection were to be avoided com-
pared to 70% of Cambodian respondents [75].
More Vietnamese than Chinese knew that hepatitis B
infection could be asymptomatic or could lead to liver
cancer, whereas more Chinese than Vietnamese identi-
fied the disease as life-long and that treatment were
available [94]. In another study, Koreans were more
likely to affirm that HBV infection causes liver cancer
than the Hmong, and perceived susceptibility was high-
est among Korean Americans and lowest among
Hmong [75]. The Turkish-Dutch participants were the
least aware that HBV infection could cause death [92],
followed by Chinese in the Netherlands [93], while
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Chinese Americans have consistently reported high
level of awareness. In contrast, evidence implies that ap-
proximately 1 in 3 Vietnamese respondents were not
aware that HBV infection could cause liver cancer
[67,72,75,76,82,87,94]. In addition, the knowledge of
this aspect of HBV infection in the Australian Vietnam-
ese sample was comparatively lower than that reported
in studies among Chinese in North America [64,73,85].
The studies in our sample indicated that gender might
influence the level of knowledge, with more women
likely to believe that hepatitis B infection could be
cured. One of the possible explanations for the variation
of level of knowledge of treatability of hepatitis infec-
tion among the Cambodians [81], Laotians [99], and
Chinese [71,89,90] compared to Vietnamese [76,82]
could be gender as Cambodian [81] and Chinese sam-
ples [89,90] were either all female or made up of greater
proportion of females [71,99]. One in six Chinese
women [89,90] were aware that HBV could not be cured
compared to a very low awareness of this among studies
of male or mixed gender participants. It is not clear
what impact the knowledge of either curability or incur-
ability of HBV and HCV could differentially have on the
men’s vis a vis women’s uptake of screening, vaccin-
ation, and treatment. Other studies found that gender
did not have an influence on the level of knowledge of
HBV [64,67,84,88,94].
Synthesised evidence suggests that other aspects of
knowledge of HBV infection influence the understanding
of the consequences of the infection. For instance, it
seems that among the Chinese and Vietnamese respon-
dents who knew that HBV infection can be asymptom-
atic had a better knowledge of HBV [95] than those
participants who thought otherwise [64,85,86,90]. This
in turn is likely to encourage people to seek screening to
determine if they are infected rather than relying on ex-
perience of symptoms. Conversely, the belief that HBV
infection is a transient infection [71,98] would lead to it
not being taken seriously.
Discussion
Summary of findings
The evidence in the systematic narrative review has
mostly emerged from studies of South East Asians in the
USA, Canada, and (to a lesser extent) Australia. We
found very little research on immigrants from other
areas with high prevalence of HBV and HCV infections,
such as Central Asian republics, South Asia, Africa,
Middle East, and Eastern Europe. Most studies in our
sample investigated knowledge of HBV infection. Most
studies identified were surveys, with a few qualitative
studies, generally confirming some of the quantitative
findings. Different surveys showed striking differences in
levels of awareness and knowledge of all aspects of HBV
and HCV infections from the nature of these infections,
and transmission factors, to how to prevent and treat
them in both acute and chronic phases. Some of these
differences, evidenced among and between ethnic
groups, may be explained by socio-economic and demo-
graphic factors, country of origin (viral infections is
highly stigmatised and people are discriminated against
in places like China), and experiences with migration
(some countries require migrants to be screened before
immigration).
The evidence indicates that many, though not all, im-
migrants lack adequate knowledge of the aetiology,
symptoms, transmission risk factors, prevention strat-
egies, consequences and treatment of HBV and HCV in-
fections. The lack of adequate knowledge is particularly
evidenced in: (a) the disconnect between having heard of
HBV infection or liver cancer and understanding of the
health implications of chronic HBV and HCV infections;
(b) confusion about the difference between various types
of viral hepatitis; (c) the low level of knowledge of main
transmission risk factors, especially sexual contact (hori-
zontal transmission) and child birth (vertical transmis-
sion), and the incorrect attribution of cause and
transmission principally to lifestyle activities and cultural
practices around food; and (d) poor level of knowledge of
chronicity of HBV infection. It is apparent that immi-
grants remain vulnerable to the spread of HBV and HCV
infections within their ethnic communities; and some are
dying prematurely from these infections, partly because of
inadequate level of knowledge.
The published evidence indicates that many, though
not all, South East Asian immigrant groups have inad-
equate or confused knowledge of HBV and HCV infec-
tions, and that this could affect their willingness to
participate in screening and treatment programmes. For
example, folk models of these conditions commonly at-
tribute them to damaged or weak liver, poor hygiene and
sanitation, and food-related factors. Transmission of
HBV and HCV infections was often attributed by immi-
grants to sanitation, contaminated food, and cultural
practices around the communal sharing of food and
utensils and HBV infection was not widely perceived to
be a sexually transmitted infection.
Another component of the ‘lay epidemiology’ of HBV
infection in some immigrant groups is social factors
such as incarceration, deprivation, hard work, stressful
lifestyle, and physical exhaustion; these perceptions may
reflect an association of the condition in some settings
with social determinants of health (in particular, poverty
and overcrowding), but the assumed causal link may
interfere with health education about transmission of a
blood borne virus. In some studies, immigrants had ap-
propriated biomedical knowledge including medical
terms and clinical markers to make sense of the
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infections. However, such (apparent) knowledge often
masked a more general confusion about the nature and
natural history of the conditions, partly because of the
asymptomatic latent (but still highly contagious) stage
was under-recognised, and because the symptoms asso-
ciated with HBV and HCV infections such as abdominal
pain, dark urine, fever, joint pain, nausea, fatigue, and
jaundice are associated with many infectious diseases in
the developing word.
Strengths and limitations of this study
A particular strength of this review lies in its synthesis
of findings from qualitative and quantitative studies. As
such the review has provided rich evidence on the na-
ture and type of knowledge of HBV and HCV infections
as well as quantitative data on levels of knowledge. Even
though we employed a Mixed Methods Appraisal Tool
(MMAT) for methodological quality assessment of stud-
ies, we included all the publications, which added a layer
of depth in our synthesis. Due to significant heterogeneity
in methodological approaches and findings of quantitative
studies, we did not undertake a meta-analysis. In addition,
this has compromised the scope for comparison of results
from different studies across regions, countries, as well as
among and between immigrant ethnic groups. Specifically,
we did not test for acculturation related factors that might
associate with health literacy, nor were we able to make
country comparisons, for example, of Chinese people in
the US, Australia, or Canada.
Since we included only studies published in peer-
reviewed journals in English, it is possible that we ex-
cluded some important publications, especially in grey
literature such as theses and reports, but given the dearth
of literature this is unlikely given out focus on ethnic
groups and immigrants.
Conclusions
Many immigrants have inadequate knowledge of HBV
and HCV infections. These findings have implications
for public health interventions aimed at stemming the
rise in prevalence of HBV and HCV but also that of liver
cancer through screening and treatment. Despite the dif-
ferences in levels knowledge and types of explanatory
models among different ethnic groups, the public health
interventions indicated would be similar, just as the
drivers of health-seeking behaviour. Using an adapted
PEN-3 model [46-48], we have developed a guide (in-
cluding strategies and approaches) that can be used by
service providers targeting immigrants (Additional file 1:
Table S6). We have further demonstrated how the model
could be used to influence specific ‘negative’ knowledge,
attitudes, and beliefs while also reinforcing the ‘positive’
or ‘neutral’ ones, most of which exist across the ethnic
groups.
This review has identified several gaps in the current evi-
dence of knowledge of HBV and HCV infections among
immigrants. The overarching aim of further research
would be to identify knowledge related barriers, and de-
velop interventions, strategies, and approaches that might
positively influence migrants’ uptake of screening, vaccin-
ation, and clinical management of chronic HBV and HCV,
and prevent the rising rates of hepatocellular carcinomas,
and liver cancer. In addition, further research is needed on:
migrants’ experiences with chronic HBV and HCV; immi-
grants’ experiences with interventions (education, screen-
ing, vaccination, and treatment); immigrants’ knowledge of
HCV; and knowledge of HBV and HCV infections among
diverse range of migrant groups in different migrant-
receiving countries. In addition, studies are needed to de-
termine factors that influence the nature, types and level of
knowledge that immigrants hold, and uptake of screening,
vaccination and treatment (including what immigrants
think could be appropriate interventions). The findings
challenge public health institutes to develop local needs as-
sessments and cross-national projects.
Additional file
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